675PDPOLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)
Hammel, P, Kindler, H L, Reni, M, Van Cutsem, E, Macarulla Mercade, T, Hall, M J, Park, J O, Hochhauser, D, Arnold, D, Oh, D-Y, Reinacher-Schick, A, Tortora, G, Algül, H, O’Reilly, E M, McGuinness, D,Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.003
Date:
October, 2019
File:
PDF, 90 KB
2019
File converter
More search results
More benefits 
